Market Analysis

Infinite Possibilities

Posted by:

Professor Meir Pugatch spoke at the launch of the fourth edition of the U.S. Chamber’s International IP Index. Titled: Infinite Possibilities, this edition maps and benchmarks the intellectual property environment in 38 economies, which together account for nearly 85% of global gross domestic product (GDP). On the whole, while challenges and setbacks still exist across the board, many of the benchmarked countries have taken positive steps and improved their IP environments. The Index also includes a special annex which underscores ...

Continue Reading →
0

The Next Frontier in Ensuring the Quality of Medicines: Maintaining International Quality and Safety Standards in the Manufacturing and Supply of Active Pharmaceutical Ingredients

Posted by:

Today Pugatch Consilium launches The Next Frontier in Ensuring the Quality of Medicines: Maintaining International Quality and Safety Standards in the Manufacturing and Supply of Active Pharmaceutical Ingredients. Authored by Professor Meir Pugatch, Dr. David Torstensson and Ma’ayan Laufer this report provides a deep-dive analysis of the next generation of challenges facing drug regulators across the globe.

Pharmacovigilance is the name given to the mechanisms and tests that together map and ensure the safety of a medicine throughout its life span ...

Continue Reading →
0

The Evolution of Pharmacovigilance: Labeling, Packaging and Pharmacopeia Standards

Posted by:

Today Pugatch Consilium launches The Evolution of Pharmacovigilance: Labeling, Packaging and Pharmacopeia Standards. Authored by Professor Meir Pugatch, Dr David Torstensson and Ma’ayan Laufer this report provides a deep-dive analysis of the next generation of challenges facing pharmacoviglance regulators.

Pharmacovigilance is the name given to the mechanisms and tests that together map and ensure the safety of a medicine throughout its life span – from test tube to patient. As patients and healthcare professionals around the world access and use more ...

Continue Reading →
0

Clinical Data and Disclosure Policies

Posted by:

Pugatch Consilium, in partnership with the US Chamber’s Global Intellectual Property Center, releases Clinical Data and Disclosure Policies: The European Union, Member States, and International Best Practices. This report provides an exhaustive analysis of the clinical data transparency aspects of EU Parliament Regulation 536/2014 on clinical trials and EMA’s finalized policies on Publication and Access to Clinical Trials Data, as well as a review of the wider policy implications and interface of these policies vis-á-vis current data disclosure policies at ...

Continue Reading →
0

The US Chamber and Pugatch Consilium launch the third edition of the GIPC IP Index

Posted by:

This week Pugatch Consilium, in partnership with the US Chamber’s Global Intellectual Property Center, released the third edition of the annual GIPC International IP Index. The 2015 edition of the Index, entitled UP: Unlimited Potential, maps the intellectual property environment in 30 economies. Overall, although challenges remain across the board, positive steps are being taken in many of the economies included in the Index. In fact, 20 of the economies mapped in 2014 improved their scores in the 2015 edition. The ...

Continue Reading →
0

Developing a Culture of Pharmacovigilance

Posted by:

Today Pugatch Consilium launches Developing a Culture of Pharmacovigilance. Authored by Professor Meir Pugatch, Dr David Torstensson and Ma’ayan Laufer this report examines one of the most important facets of a high quality drug regulatory structure, namely that of pharmacovigilance.

Pharmacovigilance is the name given to the mechanisms and tests that together map and ensure the safety of a medicine throughout its life span – from test tube to patient. As patients and healthcare professionals around the world access and ...

Continue Reading →
0

Understanding the drivers of biopharmaceutical clinical research: Why do some countries get all the investment?

Posted by:

Today Pugatch Consilium releases Scaling Up Global Clinical Trial Activity: Key Trends and Policy Lessons. This study uses regression analysis of data on 50 countries to provide a roadmap for creating a policy environment that is conducive to clinical trials. The study also benchmarks performance in the level of scope of clinical trial activity.
The main messages of the report are:

  • The creation of a pro-innovation culture is just as, if not more, important as improvements to health system capacity for ...
Continue Reading →
0

The Creative Industries and the BRICS – full report is now available on our site!

Posted by:

A review of the state of the creative economy in Brazil, Russia, India, China and South Africa

This review examines the state of the creative economy in the biggest emerging economies in the world namely Brazil, Russia, India, China and South Africa – the BRICS. Although at different levels of development, these economies are in many ways undergoing similar transitions from economies based on manufacturing, industrial output and natural resources to economies in which economic activity is ...

Continue Reading →
0
Page 4 of 5 12345